Skip to ContentSkip to Navigation
founded in 1614  -  top 100 university
About us Practical matters How to find us prof. dr. H.J. (Hiddo) Lambers Heerspink
University Medical Center Groningen

prof. dr. H.J. (Hiddo) Lambers Heerspink

Clinical Pharmacologist
Profile picture of prof. dr. H.J. (Hiddo) Lambers Heerspink
Telephone:
E-mail:
h.j.lambers.heerspink umcg.nl

Publications

Adolescents With Type 1 Diabetes Using Dapagliflozin as an Adjunct-to-Insulin: Perspectives on Experiences of Clinical Trial Participation

A Dose of Perspective: A Multinational Survey of Patient and Clinician Views on Combination Therapy in CKD

A Hierarchical Composite Endpoint for Chronic Kidney Disease Progression in Patients with Focal Segmental Glomerulosclerosis

A meta-analysis of albuminuria as a surrogate endpoint for kidney failure

Association between Complete Proteinuria Remission and Kidney Function in the Phase 3 PROTECT Trial of Sparsentan in IgA Nephropathy

Association of Tirzepatide With Kidney Parameters in Participants With Obesity and Prediabetes From SURMOUNT-1 Over 176 Weeks

Association of UACR and UPCR with kidney failure: a pooled analysis of clinical trials

Association of Urinary EGF with Kidney Outcomes and Effects of Sodium-Glucose Cotransporter 2 Inhibition

Atrasentan in patients with IgA nephropathy (ALIGN): final 2·5-year results from a randomised, double-blind, placebo-controlled, phase 3 trial

Authors' Reply: Convergent Proteinuria Reduction across Distinct Therapeutic Pathways in IgA Nephropathy

Press/media

This drug could help millions keep their kidneys working longer

HMN 2026: How Kidney drug finerenone may help millions more patients after three major studies

Geen voordeel van lage dosis rivaroxaban bij patiënten met gevorderde nierschade

Onderzoek UMCG: finerenone werkt ook goed bij grote groep patiënten met chronische nierschade

The Hidden Threat: Transforming CKD Care Across the Diabetes Spectrum

Nonsteroidal MRA & SGLT2i in People With CKD & T2D: Current Evidence and Rationale for Combination Therapy

Finerenone Improves UACR in T1D, CKD

'Nieuw' medicijn vermindert nierschade bij diabetespatiënten

Sustainable Development Goals

SDG 3 - Good Health and Well-beingSDG 9 - Industry, Innovation, and InfrastructureSDG 16 - Peace, Justice and Strong Institutions

More information about the Sustainable Development Goals.